The First Affiliated Hospital of Zhengzhou University: all 124 studies

Page 1 of 2. Open to participants first (72), then studies with results posted, then the rest; newest registration first within each.

• A Single-Arm Study of QL1706 Combined With DOS as Neoadjuvant Therapy for Locally Advanced Gastric/GEJ AdenocarcinomaNot yet recruitingNCT07828873Phase 2
• Retlirafusp Alfa Combined With Famitinib, Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic CancerNot yet recruitingNCT07814859Phase 2
• A Prospective, Multicenter, Randomized Controlled Trial Investigating the Impact of Fasting Duration on Postoperative Rebleeding Following Esophageal Variceal Ligation.RecruitingNCT07774143Not applicable
• A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric CancerRecruitingNCT07770113Phase 2
• Standardized MRI and Structured Reporting for Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07769658
• Pro-urokinase for Extended-Window Posterior Circulation StrokeNot yet recruitingNCT07617870Phase 3
• A Prospective, Single-arm Clinical Study on the Safety and Efficacy of Ivoximab Combined With Temozolomide in the Treatment of Relapsed/Refractory GliomaRecruitingNCT07599371Phase 1/2
• Tenecteplase for Late-Window Stroke Guided by DWI-FLAIR MismatchNot yet recruitingNCT07540416Phase 3
• Effect of a Novel Colonoscopic Lavage Solution on Colonoscopy QualityNot yet recruitingNCT07501975Not applicable
• Effect of Intraluminal Administration of Menthol Solution During Colonoscopy on Colonic Spasm and Adenoma Detection RateNot yet recruitingNCT07501962Not applicable
• Clinical Outcomes of Drug-Coated Balloons in the Treatment of Patients With Coronary De Novo Chronic Total Occlusion LesionsRecruitingNCT07463664Not applicable
• The Effect of Blood Flow Restriction Training Combined With Transcranial Magnetic Stimulation on Limb Function in Hemiplegic Patients After StrokeNot yet recruitingNCT07454954Not applicable
• A Phase III Study of First-line Anlotinib Combined With Benmelstobart in Patients With Advanced Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07446335Phase 3
• IBI363 Plus Bevacizumab With or Without Nab-Paclitaxel for Second-Line Treatment of Advanced Gastric CancerNot yet recruitingNCT07361991Phase 1/2
• Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian CancerNot yet recruitingNCT07314619Phase 2
• PDL1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric CancerRecruitingNCT07294664Phase 2
• Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.RecruitingNCT07169656
• A Single-center, Multicohort, Phase II Clinical Study Evaluating the Combination Therapy of Sacituzumab Tirumotecan in Patients With Unresectable, Locally Advanced, Recurrent, or Metastatic Esophageal Squamous Cell CarcinomaNot yet recruitingNCT07128693Phase 2
• Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical CancerRecruitingNCT07104149Phase 2
• Irinotecan Liposome II + 5-FU/LV + Oxaliplatin + Karelizumab in Neoadjuvant Treatment of Gastric CancerNot yet recruitingNCT07085273Phase 2
• Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell CancerRecruitingNCT07016724Phase 2
• NR vs. Vitamin E in Enhancing FertilityNot yet recruitingNCT06950736Not applicable
• Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)RecruitingNCT06930586
• A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence RiskRecruitingNCT06930573Phase 4
• Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaEnrolling by invitationNCT06901622Phase 2
• Randomized Trial of Glutathione With Anti-PD-1 and Chemotherapy in Advanced NSCLCRecruitingNCT06896422Phase 1
• Energy CT in Imaging and Diagnosis of Gastric CancerRecruitingNCT06869694
• Short-course Radiotherapy Followed by CAPOX and Ivonescimab for Locally Advanced Rectal CancerNot yet recruitingNCT06760520Phase 2
• Bevacizumab Neoadjuvant Therapy for New High-grade Gliomas in the BrainRecruitingNCT06747728Not applicable
• Efficacy and Safety of QL1706 Plus Lenvatinib As 2nd Line Theapy in Patients with Metastatic Esophageal Carcinoma After Disease Progression on ICIs TherapyNot yet recruitingNCT06746961Phase 1/2
• Nimotuzumab Combined With Sintilimab and Chemotherapy for Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT06718205Phase 2
• A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06564545Phase 2
• A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06564493Phase 2
• A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06559345Phase 2
• A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06557161Phase 2
• RC48 Plus AK104 as First-line Treatment for HER2-overexpressing Advanced Gastric CancerNot yet recruitingNCT06492317Phase 2
• Effects of ITBS Combined with NMES on Dysphagia After StrokeEnrolling by invitationNCT06464835Not applicable
• Adjuvant Treatment With Serplulimab，Trastuzumab and SOX in the HER-2 Positive GC/GEJCNot yet recruitingNCT06439550Phase 2
• Anlotinib Combined With Penpulimab as Front-line Treatment in Advanced Non-small Cell Lung CancerRecruitingNCT06341530Phase 2
• Adebrelimab Plus Cetuximab and Chemotherapy for Patients With RAS/BRAF Wild-Type Unresectable Liver Metastases Colorectal CancerRecruitingNCT06231017Phase 2
• Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal AchalasiaRecruitingNCT06213662Not applicable
• Cortical Function Changes During Swallowing in Patients With Dysphagia in Lateral Medullary SyndromeRecruitingNCT06208020
• Effect of Botulinum Toxin Injection Into Upper Esophageal Sphincter in Patients With Medullary InfarctionRecruitingNCT06196606Not applicable
• Duration of Adjuvant Chemotherapy for Gastric Cancer Patients at Pathological N3 StageRecruitingNCT06194981
• Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective StudyRecruitingNCT06194968
• IBI110 Combined With Sintilimab in Second-line Advanced or Metastatic Esophageal Squamous Cell Carcinoma(ESCC)Not yet recruitingNCT06078657Phase 2
• Candonilimab (AK104) Plus Preoperative Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (ESCC)Not yet recruitingNCT05896787Phase 2
• Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal CancerNot yet recruitingNCT05841134Phase 2
• Anlotinib Plus TQB2450 Combined With Nab-paclitaxel and Cisplatin as First-line Treatment for Advanced Biliary Tract CancerRecruitingNCT05812430Phase 2
• Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCCRecruitingNCT05738434Phase 2
• Efficacy, Safety and Exploratory Clinical Study of Bevacizumab Combined With Oxaliplatin and TAS-102 in First-line Treatment of Advanced Colorectal CancerNot yet recruitingNCT05364489Phase 2
• Study of Tislelizumab Combined With DisitamabVedotin and Pyrotinib Maleate in HER2-positive or Mutated Advanced Colorectal Cancer Who Failed Standard TherapyNot yet recruitingNCT05350917Phase 2
• Angiogenesis Inhibitor Plus Anti-PD-1/PD-L1 Antibody in Advanced Esophageal CancerRecruitingNCT05349045
• MRD-guided Adjuvant Tislelizumab and Chemotherapy in Resected Stage IIA-IIIB NSCLCRecruitingNCT05286957Phase 2
• A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) CancerNot yet recruitingNCT05241899Phase 2
• A Phase II Study of Tislelizumab as Adjuvant Therapy for Patients With Stage Ⅱ and Stage Ⅲ Colon Cancer and dMMR/MSI.Not yet recruitingNCT05231850Phase 2
• Study of Camrelizumab in Combination With Apatinib Mesylate Plus Albumin-bound Paclitaxel and Cisplatin as the First Line Treatment of Recurrent or Metastatic, UnresectableHead and Neck Squamous Cell CarcinomaNot yet recruitingNCT05189184Phase 2
• An Exploratory Study of Surufatinib Combined With Chidamide and Fulvestrant in HR Positive Unresectable Metastatic Breast CancerRecruitingNCT05186545Phase 2
• A Study of Perioperative Camrelizumab Combined With Chemotherapy in Patients With Resectable ESCCRecruitingNCT05182944Phase 2
• Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre SyndromeNot yet recruitingNCT05114941Not applicable
• Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGCRecruitingNCT04819971Phase 2
• Histopathology Images Based Prediction of Molecular Pathology in Glioma Using Artificial IntelligenceRecruitingNCT04217044
• MR Based Prediction of Molecular Pathology in Glioma Using Artificial IntelligenceRecruitingNCT04217018
• Prediction of Therapeutic Response of Apatinib in Recurrent GliomasRecruitingNCT04216550
• Survival Significance of Molecular Pathology and Genetic Variation in Brain GliomasRecruitingNCT04216537
• Histopathology Images Based Survival Prediction of Glioma Patients Using Artificial IntelligenceRecruitingNCT04215224
• MR Based Survival Prediction of Glioma Patients Using Artificial IntelligenceRecruitingNCT04215211
• Newborns From Patients Treated With ART (Assisted Reproductive Technology)RecruitingNCT03993158
• Azoospermia PatientsRecruitingNCT03991663
• PCOS (Polycystic Ovarian Syndrome) PatientsRecruitingNCT03991507
• Primary Ovarian Insufficient PatientsRecruitingNCT03989154
• A Phase II Exploratory Clinical Trial of Multiple Drug Combinations in the Treatment of Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT03736863Phase 2
• Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined With Tislelizumab and Regorafenib as First-Line Therapy for Advanced CholangiocarcinomaCompletedNCT07619937Phase 2
• Comparison of the Integrated Posterior-Anterior-Lateral Approach and the Posterior Approach in Robotic Radical ProstatectomyCompletedNCT07305142Not applicable
• Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic NetworkActive, not recruitingNCT07203495
• Tumor Microenvironmental Collagen Signature to Predict Thyroid Cancer Superior Mediastinal Lymph Node MetastasisCompletedNCT06791174
• Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid CancerCompletedNCT06697782Phase 4
• A Clinical Study on Ozone Autohemotherapy for the Treatment of Acute Ischemic StrokeCompletedNCT06525792Not applicable
• The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19CompletedNCT06349655
• Genetic Research on High Myopic Individuals in Northern ChinaCompletedNCT06204211
• Mindfulness Yoga and Sexual FunctioningStatus unknownNCT05461534Not applicable
• Esophageal Arterial Infusion Chemotherapy Versus Systemic Intravenous Chemotherapy for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: a Prospective, Multicentre, Randomised Controlled Clinical StudyStatus unknownNCT05381636Phase 2
• A Clinical Study of Herombopag in Tumors-associated ThrombocytopeniaStatus unknownNCT05350956Phase 2
• A Study of Intrapleural Administration of Bevacizumab and Camrelizumab for Malignant Pleural EffusionStatus unknownNCT05330065Phase 1/2
• Decitabine Plus Penpulimab as Second-line Therapy for Advanced ESCC Treated With PD-1 BlockadeStatus unknownNCT05265962Phase 2
• AK105 Combined With Anlotinib in Patients With Cervical CancerActive, not recruitingNCT05137171Phase 2
• Tislelizumab in Addition to BACE in Patients with NSCLCCompletedNCT05058560Phase 2
• Anlotinib Combined With TQB2450 (PD-L1 Inhibitor) in the Treatment of Advanced Esophageal Squamous Cell Carcinoma(ESCC)Active, not recruitingNCT05038813Phase 2
• Fruquintinib Combined With Toripalimab and SOX Regimen in the First-line Treatment of Advanced Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaStatus unknownNCT05024812Phase 1/2
• Chidamide Plus Camrelizumab as Second-line Therapy for Advanced ESCC Treated With PD-1 BlockadeStatus unknownNCT04984018Phase 2
• Exploring the Safety and Effectiveness of Toripalimab Combined With Neoadjuvant Radiotherapy and Chemotherapy in the Locally Advanced Esophageal Squamous Cell CarcinomaStatus unknownNCT04888403Phase 2
• Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis BStatus unknownNCT04850950Phase 4
• Study of First-line Camrelizumab With or Without Chemotherapy for Advanced Esophageal Squamous Cell CancerStatus unknownNCT04654403Not applicable
• Clinical Study on the Efficacy of Acetazolamide Combined With Levamisole in the Treatment of HCCStatus unknownNCT04611373Phase 3
• A Phase Ⅱ Clinical Trial of Camrelizumab for Adjuvant Treatment of Resectable Esophageal Squamous Cell CarcinomaStatus unknownNCT04533490Phase 2
• A Phase Ⅱ Trials of Sintilimab as Consolidation Therapy After Radical Concurrent Chemoradiotherapy in Locally Advanced Unresectable ESCCStatus unknownNCT04514835Phase 2
• Thrombolysis of Urokinase for Minor StrokeCompletedNCT04420351Phase 3
• Glioma Patients Registry Based on Radiological, Histopathological and Genetic AnalysisStatus unknownNCT04220424
• Novel Treatment of Advanced Hepatocellular CarcinomaStatus unknownNCT03950518Phase 3
• Treatment of Advanced Intrahepatic CholangiocarcinomaStatus unknownNCT03940378Phase 3

← The First Affiliated Hospital of Zhengzhou University overview and focus areas